Simplex Trading
AZN icon

Simplex Trading’s AstraZeneca AZN Stock Holding History

Simplex Trading’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.09M Sell
25,800
-27,850
-52% -$5.37M ﹤0.01% 1101
2025
Q4 		$9.86M Sell
53,650
-21,600
-29% -$3.79M 0.01% 860
2025
Q3 		$11.5M Buy
75,250
+9,450
+14% +$1.43M 0.01% 876
2025
Q2 		$9.2M Sell
65,800
-200
-0.3% -$28K 0.01% 946
2025
Q1 		$9.7M Sell
66,000
-57,650
-47% -$8.34M 0.01% 910
2024
Q4 		$16.2M Buy
123,650
+37,850
+44% +$5.3M 0.01% 751
2024
Q3 		$13.4M Sell
85,800
-27,050
-24% -$4.37M 0.01% 861
2024
Q2 		$17.6M Sell
112,850
-57,450
-34% -$8.64M 0.01% 682
2024
Q1 		$23.1M Buy
170,300
+111,250
+188% +$14.7M 0.01% 626
2023
Q4 		$7.95M Sell
59,050
-78,150
-57% -$10.2M 0.01% 1246
2023
Q3 		$18.6M Sell
137,200
-80,800
-37% -$11M 0.01% 624
2023
Q2 		$31.2M Buy
218,000
+134,150
+160% +$19.7M 0.03% 403
2023
Q1 		$11.6M Sell
83,850
-76,350
-48% -$10.3M 0.01% 821
2022
Q4 		$21.7M Buy
160,200
+37,700
+31% +$4.73M 0.02% 520
2022
Q3 		$13.4M Buy
122,500
+23,500
+24% +$2.98M 0.02% 664
2022
Q2 		$13.1M Sell
99,000
-41,750
-30% -$5.48M 0.01% 694
2022
Q1 		$18.7M Sell
140,750
-42,500
-23% -$5.1M 0.02% 568
2021
Q4 		$21.3M Buy
183,250
+21,950
+14% +$2.58M 0.02% 489
2021
Q3 		$19.5M Buy
161,300
+2,500
+2% +$291K 0.02% 468
2021
Q2 		$19M Buy
+158,800
New +$17.4M 0.02% 462
2021
Q1 		– Sell
-1,926
Closed -$19.3M – 8775
2020
Q4 		$19.3M Buy
1,926
+662
+52% +$70.1K 0.03% 366
2020
Q3 		$13.8M Buy
1,264
+517
+69% +$57.5K 0.02% 408
2020
Q2 		$7.9M Buy
747
+344
+85% +$35.5K 0.01% 610
2020
Q1 		$3.6M Buy
403
+12
+3% +$1.13K 0.01% 880
2019
Q4 		$3.9M Buy
391
+44
+13% +$4.14K 0.01% 959
2019
Q3 		$3.09M Sell
347
-295
-46% -$25.6K 0.01% 999
2019
Q2 		$5.3M Buy
642
+321
+100% +$25.2K 0.01% 653
2019
Q1 		$2.6M Buy
321
+180
+128% +$14.2K 0.01% 1142
2018
Q4 		$1.07M Sell
141
-73
-34% -$5.7K ﹤0.01% 1583
2018
Q3 		$1.69M Buy
214
+132
+161% +$9.98K 0.01% 1389
2018
Q2 		$575K Sell
82
-21
-20% -$1.51K ﹤0.01% 2320
2018
Q1 		$34K Buy
103
+3
+3% +$208 ﹤0.01% 2812
2017
Q4 		$7K Sell
100
-162
-62% -$10.9K ﹤0.01% 4171
2017
Q3 		$4K Sell
262
-665
-72% -$42K ﹤0.01% 4523
2017
Q2 		$218K Buy
927
+418
+82% +$27.3K 0.01% 1136
2017
Q1 		$60K Buy
509
+256
+101% +$14.9K ﹤0.01% 2196
2016
Q4 		$96K Sell
253
-111
-30% -$6.3K 0.01% 1565
2016
Q3 		$41K Buy
364
+163
+81% +$10.7K ﹤0.01% 2263
2016
Q2 		$65K Buy
201
+82
+69% +$4.76K ﹤0.01% 1815
2016
Q1 		$74K Buy
119
+66
+125% +$3.97K 0.01% 1600
2015
Q4 		$6K Buy
53
+37
+231% +$2.43K ﹤0.01% 3704
2015
Q3 		$9K Sell
16
-80
-83% -$5.26K ﹤0.01% 3520
2015
Q2 		$45K Buy
96
+56
+140% +$3.83K ﹤0.01% 1773
2015
Q1 		$7K Buy
+40
New +$2.78K ﹤0.01% 3194

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Simplex Trading's AZN Position: Q1 2026 in Review

Simplex Trading opened a new position in AstraZeneca (AZN) in Q1 2026: 7,753 shares worth $1.53M. The stake represents ﹤0.01% of the portfolio and ranks #2068 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AZN as recently as Q3 2025.

Simplex Trading first reported a position in AZN in Q4 2014 and has held it in 29 quarters since. The position peaked at $13.5M in Q4 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Simplex Trading held 7,753 shares of AstraZeneca worth $1.53M as of Q1 2026.
  • AstraZeneca was a new Simplex Trading position in Q1 2026.
  • AstraZeneca made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2068 holding.
  • Simplex Trading first reported a position in AstraZeneca in Q4 2014 and has held it in 29 quarters since.
  • Simplex Trading's AstraZeneca position peaked at $13.5M in Q4 2021.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.